The metabolism and anti-atherogenic properties of HDL

被引：232

作者：

Rye, Kerry-Anne ^{[1
,2
,3
]}

Bursill, Christina A. ^{[1
]}

Lambert, Gilles ^{[1
,4
]}

Tabet, Fatiha ^{[1
]}

Barter, Philip J. ^{[1
,2
]}

机构：

[1] Heart Res Inst, Lipid Res Grp, Sydney, NSW, Australia

[2] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia

[3] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia

[4] Univ Nantes, Fac Med, Nantes, France

来源：

JOURNAL OF LIPID RESEARCH | 2009年 / 50卷

基金：

澳大利亚国家健康与医学研究理事会;

关键词：

HDL remodelling; HDL subpopulations; HDL function; HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; PHOSPHOLIPID TRANSFER PROTEIN; ESTER TRANSFER PROTEIN; LIPASE-MEDIATED HYDROLYSIS; SCAVENGER RECEPTOR BI; ENDOTHELIAL LIPASE; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; GENE-TRANSFER;

D O I：

10.1194/jlr.R800034-JLR200

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Population studies have shown that plasma HDL levels correlate inversely with cardiovascular disease risk. In recent years there has been intense interest in developing strategies for exploiting these cardioprotective properties by increasing HDL levels. While this approach has considerable merit, it is important to recognize that HDL are structurally and functionally diverse and consist of numerous, highly dynamic subpopulations of particles that do not all inhibit atherosclerosis to the same extent. For this reason it is essential to assess HDL subpopulation distribution and functionality when considering therapeutic interventions that raise HDL levels. jlr This review documents what is known about the relationship between the metabolism and function of HDL subpopulations and how this affects their cardioprotective properties.-Rye, K-A., C. A. Bursill, G. Lambert, F. Tabet, and P. J. Barter. The metabolism and anti-atherogenic properties of HDL. J. Lipid Res. 2009. S195-S200.

引用

页码：S195 / S200

页数：6

共 50 条

[1] MOLECULAR BASIS OF THE ANTI-ATHEROGENIC PROPERTIES OF HDL
Calvo, Carlos
[J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2008, 20 (03): : 116 - 125
[2] PROTEIN-COMPOSITION DETERMINES THE ANTI-ATHEROGENIC PROPERTIES OF HDL IN TRANSGENIC MICE
SCHULTZ, JR
VERSTUYFT, JG
GONG, EL
NICHOLS, AV
RUBIN, EM
[J]. NATURE, 1993, 365 (6448) : 762 - 764
[3] Screening of citrus fruits on anti-atherogenic functionality of HDL
Kondo, Harumi
Kawauchi, Hibiki
Nakamaru, Yukino
Yamagishi, Keita
[J]. ANNALS OF NUTRITION AND METABOLISM, 2023, 79 : 1092 - 1093
[4] Anti-atherogenic properties of HDL: Insights from the A-I-Milano mutation
Franceschini, G
Paoletti, EG
[J]. ATHEROSCLEROSIS, 1997, 134 (1-2) : 293 - 293
[5] Ezetimibe - new anti-atherogenic properties?
Tomkin, Gerald H.
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 2009, 156 (08) : 1216 - 1217
[6] ANTI-ATHEROGENIC PROPERTIES OF CANNABIS SATIVA
Musetti, Bruno
Thomson, Leonor
Gonzalez, Mercedes
Varela, Javier
[J]. ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 128 - 129
[7] Antibodies towards HDL components in type 2 diabetes patients are associated with modifications in the anti-atherogenic properties of HDL
Batuca, J. R.
Ferreira, I.
Favas, C.
Amaral, M.
Delgado Alves, J.
[J]. DIABETOLOGIA, 2011, 54 : S277 - S278
[8] Anti-inflammatory and anti-atherogenic properties of adiponectin
Ohashi, Koji
Ouchi, Noriyuki
Matsuzawa, Yuji
[J]. BIOCHIMIE, 2012, 94 (10) : 2137 - 2142
[9] ApoA-I is required for HDL anti-atherogenic function in vivo
Moore, R
Navab, M
Hama, S
Zimetti, F
Rothblat, GH
Rader, DJ
[J]. ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 42 - 42
[10] SEARCH FOR ATHEROGENIC AND ANTI-ATHEROGENIC SUBSTANCES
SHIMAMOTO, T
YAGISHITA, I
SANO, T
HIROKI, T
SUNAGA, T
[J]. CIRCULATION, 1961, 24 (04) : 1104 - &

← 1 2 3 4 5 →